OrthoPediatrics launches the 3P Pediatric Plating Platform Hip System, enhancing pediatric orthopedic surgical options across the U.S.
Quiver AI Summary
OrthoPediatrics Corp. announced the full commercial launch of its 3P™ Pediatric Plating Platform® Hip System, following a successful limited release that saw over 350 surgical implantations. This system is now available to pediatric orthopedic surgeons across the U.S., marking a significant advancement in the treatment of proximal femur trauma and deformities. The 3P Hip System is the first in a series expected to enhance the company's Pediatric Plating Platform portfolio, featuring advanced implant technologies and improved surgical workflows. OrthoPediatrics emphasizes the importance of innovation in pediatric orthopedics, with the successful feedback from the limited launch reinforcing the system's clinical utility. Overall, this launch represents an important milestone for OrthoPediatrics and aims to expand treatment options for pediatric patients worldwide.
Potential Positives
- The full commercial launch of the 3P™ Pediatric Plating Platform® Hip System marks a significant advancement in pediatric orthopedics, showcasing OrthoPediatrics' commitment to innovation in the field.
- Over 350 successful surgical implantations during the limited launch period indicate strong validation of the product's clinical utility and demand from pediatric orthopedic surgeons.
- The introduction of the 3P Hip System establishes a foundation for a broader and technologically advanced Pediatric Plating Platform portfolio, potentially enhancing the company's market position.
- The successful collaboration with leading pediatric orthopedic surgeons reflects OrthoPediatrics' dedication to addressing the specific needs of its target market, further strengthening relationships within the industry.
Potential Negatives
- None
FAQ
What is the 3P Pediatric Plating Platform Hip System?
The 3P Hip System is a new orthopedic implant system for pediatric trauma and deformity correction, launched by OrthoPediatrics.
When was the 3P Hip System launched?
The full commercial launch of the 3P Pediatric Plating Platform Hip System occurred on August 25, 2026.
How many surgical implantations were performed during the limited launch?
Over 350 surgical implantations were completed during the successful limited launch period of the 3P Hip System.
What advancements does the 3P Hip System offer?
The 3P Hip System offers enhanced fixation options, streamlined workflow, and increased procedural versatility for pediatric orthopedic surgeons.
What is OrthoPediatrics' focus as a company?
OrthoPediatrics is focused exclusively on advancing pediatric orthopedics, providing comprehensive products for various orthopedic conditions in children.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$KIDS Insider Trading Activity
$KIDS insiders have traded $KIDS stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $KIDS stock by insiders over the last 6 months:
- DAVID R BAILEY (President and CEO) sold 19,535 shares for an estimated $336,978
- FRED HITE (COO and CFO) sold 12,993 shares for an estimated $224,129
- DANIEL J GERRITZEN (General Counsel and Secretary) sold 8,614 shares for an estimated $148,591
- JOSEPH W HAUSER (Pres. Trauma & Def. Correction) sold 8,596 shares for an estimated $148,281
- GREGORY A ODLE (President of Scoliosis) sold 8,433 shares for an estimated $145,469
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$KIDS Revenue
$KIDS had revenues of $70.5M in Q2 2026. This is an increase of 15.43% from the same period in the prior year.
You can track KIDS financials on Quiver Quantitative's KIDS stock page.
You can access data on KIDS stock through the Quiver Quantitative API.
$KIDS Hedge Fund Activity
We have seen 67 institutional investors add shares of $KIDS stock to their portfolio, and 59 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MORGAN STANLEY removed 447,731 shares (-39.2%) from their portfolio in Q2 2026, for an estimated $8,565,094
- GRANAHAN INVESTMENT MANAGEMENT, LLC added 421,983 shares (+63.6%) to their portfolio in Q2 2026, for an estimated $8,072,534
- MILLENNIUM MANAGEMENT LLC removed 420,069 shares (-34.0%) from their portfolio in Q2 2026, for an estimated $8,035,919
- AIGH CAPITAL MANAGEMENT LLC added 269,765 shares (+inf%) to their portfolio in Q2 2026, for an estimated $5,160,604
- WASATCH ADVISORS LP added 186,357 shares (+56.6%) to their portfolio in Q2 2026, for an estimated $3,565,009
- BROWN ADVISORY INC added 160,965 shares (+10.6%) to their portfolio in Q2 2026, for an estimated $3,079,260
- BROWN CAPITAL MANAGEMENT LLC removed 157,234 shares (-50.6%) from their portfolio in Q2 2026, for an estimated $3,007,886
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$KIDS Analyst Ratings
Wall Street analysts have issued reports on $KIDS in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BTIG issued a "Buy" rating on 05/01/2026
To track analyst ratings and price targets for $KIDS, check out Quiver Quantitative's $KIDS forecast page.
$KIDS Price Targets
Multiple analysts have issued price targets for $KIDS recently. We have seen 3 analysts offer price targets for $KIDS in the last 6 months, with a median target of $24.0.
Here are some recent targets:
- Ryan Zimmerman from BTIG set a target price of $24.0 on 05/01/2026
- Richard Newitter from Truist Securities set a target price of $20.0 on 03/02/2026
- Mike Matson from Needham set a target price of $30.0 on 02/27/2026
Full Release
WARSAW, Ind., Aug. 25, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the full commercial launch of its 3P™ Pediatric Plating Platform ® Hip System.
Following a highly successful limited launch period that resulted in over 350 surgical implantations, the system is now broadly available to pediatric orthopedic surgeons throughout the United States. The 3P Hip System is the first system within the Company's broader Pediatric Plating Platform portfolio and represents a significant advancement in trauma and deformity correction.
"The response to the 3P Hip System during the limited launch period exceeded our expectations," said Joe Hauser, President of Trauma & Deformity and OPSB at OrthoPediatrics. "With over 350 surgical implantations completed prior to full commercialization, surgeons have validated both the clinical utility of the system and the need for continued innovation in plating technologies. This achievement reflects years of collaboration with leading pediatric orthopedic surgeons and our dedicated development team, and we're excited to now make the system broadly available to customers nationwide."
The 3P Pediatric Plating Platform Hip System was designed to modernize plating through advanced implant and instrumentation technologies that provide enhanced fixation options, streamlined workflow, and broad procedural versatility. The comprehensive system includes Locking Proximal Femur Plates and Beam Screw constructs available in Infant, Child, and Adolescent configurations for the treatment of proximal femur trauma and deformities.
The 3P Hip System is the first of several planned Pediatric Plating Platform systems expected to transform the Company's plating portfolio and expand treatment options for pediatric orthopedic surgeons worldwide.
David Bailey, President and Chief Executive Officer of OrthoPediatrics, commented, "The full commercial launch of the 3P Pediatric Plating Platform Hip System is an important milestone for OrthoPediatrics and our Trauma & Deformity business. The success of the limited launch validates both the strength of the product and the demand for continued innovation in pediatric orthopedics. As the first system within our broader Pediatric Plating Platform family, 3P Hip establishes the foundation for what we believe will become the most comprehensive and technologically advanced plating portfolio in pediatric orthopedics."
About OrthoPediatrics Corp.
Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such, it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets over 90 systems that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and over 75 countries outside the United States. For more information, please visit
www.orthopediatrics.com
. For more information about the OrthoPediatrics Specialty Bracing portfolio, please visit
www.opsb.com
.
Investor Contact
Philip Taylor
Gilmartin Group
[email protected]
